MedWatch

Novo Nordisk wins big on strong US dollar

The sharply rising US dollar exchange rate compared to the Danish krone is very lucrative for Danish firms. Novo Nordisk is the clear winner, but many other healthcare companies also stand to benefit.

Photo: Jacob Gronholt-Pedersen/REUTERS / X04292

Danish business, with pharmaceutical flagship Novo Nordisk at the forefront, is winning big on a dramatic rise in the US dollar exchange rate.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs